| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Secretary and General Counsel
1 company
Novack Jeffrey Adam serves as a Secretary and General Counsel at CDNA. Across recent SEC filings that breaks down to 0 buys and 17 sells. Those positions are worth an estimated $7.0M at current prices.
Historically, Novack Jeffrey Adam's trades have earned a middling insider score of 62/100 across 9 rated trades. Over a 12-month horizon, 71.4% of those trades were profitable, with an average 12-month return of -5.8%.
The biggest single holding is CDNA (~$7.0M) as Secretary and General Counsel. The recent filings there lean toward selling, a net 38,284 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 | CDNA Caredx, Inc. | Secretary and General Counsel | Sell10b5-1 | 6,757 | $22.17 | $149,828.81 | -5.7% | -11.4% | -25.8% |